As part of the ENDO 2025 session, “Obesity Management Across the Lifespan: Special Considerations,” Lisa Morselli, MD, PhD, talks about the unique challenges in obesity management in women during their reproductive years. On Tuesday, July 15, ENDO 2025 here in San Francisco will feature a session titled, “Obesity Management Across the Lifespan: Special Considerations.” As...
Women who work night shifts may have an increased risk for irregular periods and hormonal imbalances, according to a study being presented Monday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif. “Shiftwork-like light exposure disrupts the body’s internal timing, causing a split response where some females have disrupted reproductive cycles and...
Endocrine Society and European Society of Endocrinology suggest delivery before 39 weeks A joint guideline released today from the Endocrine Society and the European Society of Endocrinology (ESE) recommends women with diabetes receive proper preconception care and access to emerging diabetes technology and therapeutics to manage their blood sugar before, during and after pregnancy. Adverse...
What goes on in the womb does not stay in the womb as prenatal hormone exposure plays a critical role in shaping childhood growth and body composition. A recent study published in The Journal of Clinical Endocrinology & Metabolism suggests that prenatal testosterone exposure is linked to sex-specific body composition changes, with boys exposed to...
As the incidence of polycystic ovary syndrome grows, so does an increased awareness. Statistics show that nearly 10% of women have polycystic ovary syndrome (PCOS), making it one of the leading causes of infertility, and new research indicates that it seems to be on the rise. Three recent studies from The Journal of Clinical Endocrinology...
When a presentation at ENDO 2024 highlighted a male contraceptive gel that suppresses sperm production faster than other hormone-focused methods of male birth control, the Boston Convention Center was abuzz. Containing segesterone acetate and testosterone and applied to both shoulders, this groundbreaking new birth control could prove revolutionary. When the results from an ongoing multicenter...
Shumei Meng, MD, PhD, from the Baylor University Medical Center and the Texas A&M School of Medicine, discusses a remarkable case study from JCEM Case Reports detailing how endocrinologists may have discovered a new syndromic association that may have saved a pregnant patient’s life. Sometimes in medicine, everything aligns, and patients with unusual presentations who...
Injectable and gel versions of testosterone replacement therapy have long been considered cumbersome by both patients and providers, for a litany of reasons from being difficult to administer to an overwhelming insurance burden. However, research from ENDO 2024 revealed that a new oral therapy could potentially eliminate these barriers and be a safer option. By...
As part of the ENDO 2025 session, “Obesity Management Across the Lifespan: Special Considerations,” Lisa Morselli, MD, PhD, talks about the unique challenges in obesity management in women during their reproductive years. On Tuesday, July 15, ENDO 2025 here in San Francisco will feature a session titled, “Obesity Management Across the Lifespan: Special Considerations.” As...
Shumei Meng, MD, PhD, from the Baylor University Medical Center and the Texas A&M School of Medicine, discusses a remarkable case study from JCEM Case Reports detailing how endocrinologists may have discovered a new syndromic association that may have saved a pregnant patient’s life. Sometimes in medicine, everything aligns, and patients with unusual presentations who...
